These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2285827)
1. Thermospray high performance liquid chromatography/mass spectrometric identification of a bladder carcinogen metabolite isolated from guinea pig urine. Mattammal MB; Lakshmi VM; Dawley RM; Zenser TV; Davis BB; Hsu FF Biomed Environ Mass Spectrom; 1990 Oct; 19(10):601-8. PubMed ID: 2285827 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer. Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713 [TBL] [Abstract][Full Text] [Related]
3. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats. Rice JR; Spry LA; Zenser TV; Davis BB Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171 [TBL] [Abstract][Full Text] [Related]
4. Mutagenicity of urine of various species fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or 2-amino-4-(5-nitro-2-furyl)thiazole. Hayashida S; Wang CY Mutat Res; 1984 Mar; 135(3):169-73. PubMed ID: 6369128 [TBL] [Abstract][Full Text] [Related]
5. Liver NADPH-dependent oxidation of the 5-nitrofurans, FANFT and ANFT, by guinea pig and rat. Dawley RM; Lakshmi VM; Babu SR; Zenser TV; Davis BB Xenobiotica; 1993 Feb; 23(2):193-203. PubMed ID: 8498082 [TBL] [Abstract][Full Text] [Related]
6. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice. Swaminathan S; Bryan GT Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771 [TBL] [Abstract][Full Text] [Related]
7. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo. Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of nitrofurothiazole bladder carcinogens. Spry L; Lakshmi VM; Zenser T; Davis B J Pharmacol Exp Ther; 1986 Aug; 238(2):457-62. PubMed ID: 3735127 [TBL] [Abstract][Full Text] [Related]
10. Identification of 4-(5-amino-2-furyl)thiazole (AFT) as a reductive metabolite of the carcinogen 4-(5-nitro-2-furyl)thiazole (NFT). Swaminathan S; Ichikawa M; Bryan GT Carcinogenesis; 1986 Apr; 7(4):615-9. PubMed ID: 3698193 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens. Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679 [TBL] [Abstract][Full Text] [Related]
12. Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats. Wang CY; Hayashida S Cancer Lett; 1984 Aug; 24(1):37-43. PubMed ID: 6548659 [TBL] [Abstract][Full Text] [Related]
13. 'Revised' mass spectral identification of 2-amino-4-(5-nitro-2-furyl)thiazole metabolites. Mattammal MB; Lakshmi VM; Zenser TV; Davis BB; White E Biomed Environ Mass Spectrom; 1988 May; 15(9):495-9. PubMed ID: 3382804 [TBL] [Abstract][Full Text] [Related]
14. In vitro transformation of rat bladder epithelium by 2-amino-4-(5-nitro-2-furyl)thiazole. Mann AM; Masui T; Chlapowski FJ; Okamura T; Borgeson CD; Cohen SM Carcinogenesis; 1991 Mar; 12(3):417-22. PubMed ID: 2009588 [TBL] [Abstract][Full Text] [Related]
15. Bioconversion and macromolecular binding of 2-amino-4-(5-nitro-2-furyl)thiazole by cultured rat urothelial cells. Swaminathan S; Johnson MD; Reznikoff CA; Bryan GT Cancer Res; 1984 Dec; 44(12 Pt 1):5511-6. PubMed ID: 6498813 [TBL] [Abstract][Full Text] [Related]
16. 13-cis-retinoic acid: effect on urinary bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in Fischer rats. Croft WA; Croft MA; Paulus KP; Williams JH; Wang CY; Lower GM Cancer Lett; 1981 May; 12(4):355-60. PubMed ID: 6946855 [TBL] [Abstract][Full Text] [Related]
17. Mutagenicity, carcinogenicity, distribution, and nitroreduction of 4-(5-nitro-2-furyl)thiazole in the rat. Swaminathan S; Ertürk E; Bryan GT Cancer Res; 1981 Jul; 41(7):2648-53. PubMed ID: 7018666 [TBL] [Abstract][Full Text] [Related]
18. Formation of thioether conjugates of the bladder carcinogen ANFT catalyzed by prostaglandin H synthase. Rice JR; Zenser TV; Davis BB Carcinogenesis; 1985 Apr; 6(4):585-90. PubMed ID: 3921273 [TBL] [Abstract][Full Text] [Related]
19. neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells. Mann AM; Asamoto M; Masui T; Macatee T; Eklund SH; Cohen SM Cancer Lett; 1994 Sep; 84(2):125-31. PubMed ID: 7915641 [TBL] [Abstract][Full Text] [Related]
20. Effect of aspirin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat. Hasegawa R; St John M; Murasaki G; Fukushima S; Cohen SM Cancer Lett; 1984 Jan; 21(3):269-75. PubMed ID: 6692345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]